These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 34662439)
1. Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis. Hu K; Perez-Matos MC; Argemi J; Vilar-Gomez E; Shalaurova I; Bullitt E; Landeen L; Sugahara G; Deng H; Mathur K; Tran S; Cai H; He H; Yalcin Y; Vieira Barbosa J; Ventura-Cots M; Marx K; Gad AP; Niezen S; Izunza Barba S; Ang LH; Popov YV; Fricker Z; Lai M; Curry M; Afdhal N; Szabo G; Mukamal KJ; Sanyal AJ; Otvos JD; Malik R; Saito T; Connelly MA; Chalasani NP; Bataller R; Jiang ZG Hepatology; 2022 Apr; 75(4):968-982. PubMed ID: 34662439 [TBL] [Abstract][Full Text] [Related]
2. Circulating high density lipoprotein distinguishes alcoholic hepatitis from heavy drinkers and predicts 90-day outcome: lipoproteins in alcoholic hepatitis. Mathur K; Vilar-Gomez E; Connelly MA; He H; Sanyal AJ; Chalasani N; Jiang ZG J Clin Lipidol; 2021; 15(6):805-813. PubMed ID: 34756674 [TBL] [Abstract][Full Text] [Related]
3. Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein. van den Berg EH; Flores-Guerrero JL; Gruppen EG; Garcia E; Connelly MA; de Meijer VE; Bakker SJL; Blokzijl H; Dullaart RPF J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268313 [TBL] [Abstract][Full Text] [Related]
4. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product. Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103 [TBL] [Abstract][Full Text] [Related]
6. Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay. Bedi S; Garcia E; Jeyarajah EJ; Shalaurova I; Perez-Matos MC; Jiang ZG; Dullaart RPF; Matyus SP; Kirk WJ; Otvos JD; Davidson WS; Connelly MA J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32927635 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020 [TBL] [Abstract][Full Text] [Related]
8. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2. Dashti N; Alaupovic P; Knight-Gibson C; Koren E Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101 [TBL] [Abstract][Full Text] [Related]
9. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis. Sehrawat TS; Arab JP; Liu M; Amrollahi P; Wan M; Fan J; Nakao Y; Pose E; Navarro-Corcuera A; Dasgupta D; Liao CY; He L; Mauer AS; Avitabile E; Ventura-Cots M; Bataller RA; Sanyal AJ; Chalasani NP; Heimbach JK; Watt KD; Gores GJ; Gines P; Kamath PS; Simonetto DA; Hu TY; Shah VH; Malhi H Hepatology; 2021 Feb; 73(2):571-585. PubMed ID: 32246544 [TBL] [Abstract][Full Text] [Related]
10. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus. Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles. Bekaert ED; Alaupovic P; Knight-Gibson CS; Franceschini G; Sirtori CR J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335 [TBL] [Abstract][Full Text] [Related]
12. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery. Weidman SW; Ragland JB; Sabesin SM J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121 [TBL] [Abstract][Full Text] [Related]
13. Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis. Yang Z; Zhang T; Kusumanchi P; Tang Q; Sun Z; Radaeva S; Peiffer B; Shah VH; Kamath P; Gores GJ; Sanyal A; Chalasani N; Jiang Y; Huda N; Ma J; Liangpunsakul S Hepatology; 2021 Nov; 74(5):2436-2451. PubMed ID: 34096637 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study. Chu NF; Makowski L; Chang JB; Wang DJ; Liou SH; Shieh SM Eur J Epidemiol; 2000 Jan; 16(1):5-12. PubMed ID: 10780336 [TBL] [Abstract][Full Text] [Related]
15. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition. Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607 [TBL] [Abstract][Full Text] [Related]
16. Quantifying the contribution of lipoprotein(a) to all apoB containing particles. Chilazi M; Zheng W; Park J; Marvel FA; Khoury S; Jones SR; Martin SS J Clin Lipidol; 2022; 16(2):220-226. PubMed ID: 35241398 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) and apolipoprotein(a) in a New World monkey, the common marmoset (Callithrix jacchus). Association of variable plasma lipoprotein(a) levels with a single apolipoprotein(a) isoform. Guo HC; Michel JB; Blouquit Y; Chapman MJ Arterioscler Thromb; 1991; 11(4):1030-41. PubMed ID: 1829630 [TBL] [Abstract][Full Text] [Related]
18. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. Konishi K; Miyake T; Furukawa S; Senba H; Kanzaki S; Nakaguchi H; Yukimoto A; Nakamura Y; Watanabe T; Koizumi Y; Yoshida O; Tokumoto Y; Hirooka M; Kumagi T; Abe M; Matsuura B; Hiasa Y Atherosclerosis; 2020 Apr; 299():32-37. PubMed ID: 32203743 [TBL] [Abstract][Full Text] [Related]
19. ELISA quantitation of apolipoproteins in plasma lipoprotein fractions: ApoE in ApoB-containing lipoproteins (Lp B:E) and ApoB in ApoE-containing lipoproteins (Lp E:B). Yang CY; Xie YH; Yang M; Quion JA; Gotto AM J Protein Chem; 1995 Oct; 14(7):503-9. PubMed ID: 8561846 [TBL] [Abstract][Full Text] [Related]
20. The effect of alcohol withdrawal on serum concentrations of Lp(a), apolipoproteins A-1 and B, and lipids. Huang CM; Elin RJ; Ruddel M; Schmitz J; Linnoila M Alcohol Clin Exp Res; 1992 Oct; 16(5):895-8. PubMed ID: 1332524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]